Valued at USD 6.51 billion in 2025, the global AI in oncology market is projected to reach USD 8.26 billion in 2026 and USD 56.44 billion by 2034, growing at a CAGR of 27.1% during the forecast period 2026–2034. Precision medicine and early cancer detection capabilities are key growth drivers. Major players include Azra AI, IBM, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare,...

Polaris Market Research has published insightful research on Clinical Oncology Next Generation Sequencing Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been provided in the...

Multiple Myeloma Therapeutics Market Growing at 6.1% CAGR According to Straits Research, the global Multiple Myeloma Therapeutics Market was valued at USD 23.27 Billion in 2021 and is projected to grow from USD XX Billion in 2022 to USD 39.65 Billion by 2030, reflecting a CAGR of 6.1% over the forecast...

The Oncology Based Molecular Diagnostics Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Oncology Based Molecular Diagnostics Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive...

Market Overview Polaris Market Research’s latest research report, titled Oncology Information Systems Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies, and growth projections....